Emtricitabine
Summary
Emtricitabine is a nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV.
Background
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) indicated for the treatment of HIV infection in adults5 or combined with tenofovir alafenamide for the prevention of HIV-1 infection in high risk adolescents and adults.4 Emtricitabine is a cytidine analogue.5 The drug works by inhibiting HIV reverse transcriptase, preventing transcription of HIV RNA to DNA.5
Emtricitabine was granted FDA approval on 2 July 2003.5
Weight Average: 247.247
Monoisotopic: 247.042690096
Chemical Formula: C8H10FN3O3S